Predictors of depression, anxiety and quality of life in patients with prostate cancer receiving androgen deprivation therapy
Version of Record online: 11 MAR 2013
Copyright © 2013 John Wiley & Sons, Ltd.
Volume 22, Issue 10, pages 2169–2176, October 2013
How to Cite
Chipperfield, K., Fletcher, J., Millar, J., Brooker, J., Smith, R., Frydenberg, M. and Burney, S. (2013), Predictors of depression, anxiety and quality of life in patients with prostate cancer receiving androgen deprivation therapy. Psycho-Oncology, 22: 2169–2176. doi: 10.1002/pon.3269
- Issue online: 2 OCT 2013
- Version of Record online: 11 MAR 2013
- Manuscript Accepted: 28 JAN 2013
- Manuscript Revised: 7 NOV 2012
- Manuscript Received: 13 JUN 2012
- Abbott Pharmaceuticals. Grant Number: IIS MET-11-0029
- Cabrini Institute. Grant Number: 1068651
Options for accessing this content:
- If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
- If your institution does not currently subscribe to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.